SOURCE: iSatori

iSatori

August 27, 2014 11:00 ET

iSatori Reports Additional Clinical Data on the Impact of Bio-Gro™ Bio-Active Peptides on Muscle Recovery, Strength, and Lean Body Mass

Company Publishes White Paper Titled, "Bio-Active Peptides [BAP's]: Their Role in Protein Synthesis and Human Performance Enhancement Related to Recovery and Lean Body Mass Gains"

GOLDEN, CO--(Marketwired - Aug 27, 2014) - iSatori, Inc. (OTCQB: IFIT), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, announced today that is has published a scientific white paper titled, "Bio-Active Peptides [BAP's]: Their Role in Protein Synthesis and Human Performance Enhancement Related to Recovery and Lean Body Mass Gains." Please click here to access the white paper directly, or it can be found on www.bio-gro.org.

Authored by Darryn S. Willoughby, Ph.D., FACSM, FISSN, who is the Associate Professor, Department of Health, Human Performance; and Director, Exercise and Biochemical Nutrition Laboratory at Baylor University, in Waco, Texas, the white paper provides a more comprehensive look into the science and mechanics behind the creation of iSatori's category defining Bio-Gro™ product and presents additional clinical support and findings on the effects of bio-active peptides.

iSatori founder and Chief Executive Officer, Stephen Adele, commented, "Becoming the first sports nutrition company in history to fund clinical studies on bio-active peptides for their role in enhancing muscular performance is exciting and really sets the stage, we believe, for Bio-Gro™ and its future product developments to redefine the existing standards in muscle repair and muscle development. I am proud to have pioneered this development and honored to have Dr. Willoughby author this informative white paper."

Bio-Gro™ bio-active peptides can be found available at nationwide retailers like GNC, The VitaminShoppe, Vitamin World, and online at places like bodybuilding.com, tigerfitness.com, muscleandstrength.com, and hundreds more. Retailers interested in carrying Bio-Gro™ can contact Europa Sports, America's largest wholesaler and the exclusive distributor for iSatori, at 1-877-447-4775, or EuropaSports.com. 

About iSatori, Inc.

iSatori is a consumer products firm that develops and sells scientifically engineered nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at http://www.isatori.com.

Forward-Looking Statements

Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "potential," and similar terms and phrases to identify forward-looking statements in this press release. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. Please see our Risk Factor disclosures included in our Registration Statement on Form S-1, as amended, initially filed with the Securities and Exchange Commission on April 30, 2013, and in subsequent filings with the Securities and Exchange Commission. All future written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the previous statements. The forward-looking statements herein speak as of the date of this press release. We undertake no obligation to update any information contained herein or to publicly release the results of any revisions to any forward-looking statements that may be made to reflect events or circumstances that occur, or that we become aware of, after the date of this press release.